1. Home
  2. BNR vs SURG Comparison

BNR vs SURG Comparison

Compare BNR & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • SURG
  • Stock Information
  • Founded
  • BNR 2014
  • SURG 2006
  • Country
  • BNR China
  • SURG United States
  • Employees
  • BNR N/A
  • SURG N/A
  • Industry
  • BNR Medical Specialities
  • SURG Advertising
  • Sector
  • BNR Health Care
  • SURG Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • SURG Nasdaq
  • Market Cap
  • BNR 64.2M
  • SURG 32.4M
  • IPO Year
  • BNR 2020
  • SURG N/A
  • Fundamental
  • Price
  • BNR $4.65
  • SURG $1.38
  • Analyst Decision
  • BNR
  • SURG Buy
  • Analyst Count
  • BNR 0
  • SURG 2
  • Target Price
  • BNR N/A
  • SURG $9.50
  • AVG Volume (30 Days)
  • BNR 7.9K
  • SURG 296.6K
  • Earning Date
  • BNR 08-22-2024
  • SURG 08-13-2024
  • Dividend Yield
  • BNR N/A
  • SURG N/A
  • EPS Growth
  • BNR N/A
  • SURG N/A
  • EPS
  • BNR N/A
  • SURG N/A
  • Revenue
  • BNR $70,154,674.00
  • SURG $112,993,790.00
  • Revenue This Year
  • BNR $52.90
  • SURG N/A
  • Revenue Next Year
  • BNR $48.35
  • SURG $4.87
  • P/E Ratio
  • BNR N/A
  • SURG N/A
  • Revenue Growth
  • BNR N/A
  • SURG N/A
  • 52 Week Low
  • BNR $4.52
  • SURG $1.33
  • 52 Week High
  • BNR $11.80
  • SURG $9.23
  • Technical
  • Relative Strength Index (RSI)
  • BNR 27.01
  • SURG 24.09
  • Support Level
  • BNR $4.52
  • SURG $1.33
  • Resistance Level
  • BNR $5.10
  • SURG $1.72
  • Average True Range (ATR)
  • BNR 0.38
  • SURG 0.13
  • MACD
  • BNR -0.15
  • SURG -0.02
  • Stochastic Oscillator
  • BNR 5.36
  • SURG 7.14

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: